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Abstract
Introduction Severe acute pancreatitis (SAP) requiring
admission to a critical care unit is associated with high mortality
and long lengths of stay. We describe the case mix, outcome,
and activity of admissions with SAP who were identified from a
high-quality clinical database.
Methods We conducted a secondary analysis of the ICNARC
(Intensive Care National Audit & Research Centre) Case Mix
Programme Database of 219,468 admissions to 159 adult,
general critical care units in England, Wales, and Northern
Ireland for the period of 1995 to 2003 to identify admissions
with SAP. The ability of the modified Glasgow criteria to
discriminate hospital survivors from non-survivors was
compared to that of the Acute Physiology and Chronic Health
Evaluation (APACHE) II score and a number of individual
physiological parameters.
Results A total of 2,677 admissions with SAP were identified
(1.2% of all admissions). Mortality for these admissions was
31% in the critical care unit and 42% in hospital. The median
length of stay in the critical care unit was 3.8 days and was
similar for survivors and non-survivors. Increasing numbers of
modified Glasgow criteria were associated with increasing
hospital mortality, but better discrimination was provided by the
APACHE II score and by several physiological parameters.
Conclusion SAP requiring critical care is associated with high
mortality and long length of stay. The modified Glasgow criteria
represent a simple measure of severity but were not designed to
predict hospital mortality. It may be possible to develop a
specific model for risk prediction in patients with SAP requiring
critical care.
Introduction
Acute pancreatitis affects approximately 10 to 20 per million
of the UK population per year [1] and approximately 25% of
these require some form of critical care [2]. Severe acute pan-
creatitis (SAP) requiring admission to a critical care unit is
associated with high mortality [1,3]. Management of SAP on
the critical care unit is resource-intensive [4], and admissions
have long stays in critical care [5]. However, data on outcomes
and activity are sparse and predominantly from single special-
ist centres with limited numbers of patients.
A number of severity scoring approaches exist for acute pan-
creatitis, the most commonly used being the criteria of Ranson
and colleagues [6], the Glasgow (Imrie) criteria [7], and the
modified Glasgow criteria [8]. These scoring systems were
devised predominantly for identifying SAP, and it is not clear
how useful they are as prognostic tools in a critical care
setting.
We interrogated a large national critical care database to
ascertain the frequency of admissions with SAP,Page 1 of 8
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ity, and subsequent outcome and activity. We applied the def-
initions of the modified Glasgow criteria and compared the
discrimination of this score for predicting hospital mortality
with that of the Acute Physiology and Chronic Health Evalua-
tion (APACHE) II score and a number of physiological
parameters.
Materials and methods
Case Mix Programme Database
Data were extracted for 219,468 admissions to 159 adult,
general critical care units–intensive care units (ICUs) and
combined intensive care/high-dependency units–from the
Intensive Care National Audit & Research Centre (ICNARC)
Case Mix Programme Database (CMPD) for the period of
December 1995 to June 2003. Data were collected prospec-
tively and abstracted locally by trained data collectors accord-
ing to precise rules and definitions. The data underwent
extensive validation before incorporation into the CMPD. The
process of data validation and cleaning has been described in
detail previously [9].
Selection of cases
The primary and secondary reasons for admission to the criti-
cal care unit are coded in the CMPD by means of a hierarchi-
cal coding system, the ICNARC Coding Method [10].
Admissions were identified as having SAP if their primary rea-
son for admission was recorded as 'acute pancreatitis,'
'chronic pancreatitis,' or 'infective pancreatitis.' Admissions
transferred in from another critical care unit were excluded.
APACHE II exclusions (age less than 16 years, length of stay
less than 8 hours) were applied when calculating APACHE II
scores only [11]. Readmissions to the critical care unit within
the same hospital stay were excluded from calculation of ulti-
mate hospital mortality and length of stay in hospital.
Case mix
Age at admission and gender were extracted. Surgical status
was defined by the source of admission to the critical care unit
and (for admissions from theatre) by the National Confidential
Enquiry into Patient Outcome and Death classification of sur-
gery as elective (including scheduled) or emergency (includ-
ing urgent). Three serious conditions from the past medical
history were extracted using data collected as part of the
chronic health evaluation section of the APACHE II score [11].
These were biopsy-proven cirrhosis documented at any time
prior to or at admission to the critical care unit; hepatic
encephalopathy (grade 1 or greater) occurring within the six
months prior to admission; and steroid treatment, defined as
more than or equal to 3 mg/kg prednisolone or equivalent daily
for the six months prior to admission.
Mechanical ventilation during the first 24 hours following
admission to the unit was identified by the recording of a ven-
tilated respiratory rate. The following physiological parame-
ters, selected a priori, were extracted from the data collected
during the first 24 hours in the ICU: lowest arterial oxygen ten-
sion (PaO2), lowest PaO2/FIO2(PaO2/fractional inspired oxy-
gen) gradient, lowest arterial pH, highest serum urea, highest
serum creatinine, highest serum glucose, highest total serum
bilirubin, lowest total serum calcium, lowest ionised serum cal-
cium, lowest serum albumin, highest white blood cell count,
and lowest platelet count. Overall acute severity of illness was
summarised with the APACHE II Acute Physiology Score
(APS) and the APACHE II score.
Seven of the eight modified Glasgow criteria for assessing
severity of pancreatitis [8] were matched based on data avail-
able from the first 24 hours following admission to the unit.
These were age older than 55 years, white blood cell count
greater than 15 × 109/l, serum glucose greater than 10 mmol/
l, serum urea greater than 16 mmol/l, PaO2 less than 8 kPa,
serum albumin less than 32 g/l, and total serum calcium less
than 2 mmol/l. The remaining criterion that could not be
matched was lactate dehydrogenase more than 600 IU/l (lac-
tate dehydrogenase is not recorded in the CMPD). According
to the original definitions, these parameters should be
assessed during a 48-hour period. However, data were avail-
able for only 24 hours.
Outcome
Mortality data were collected at discharge from the admitting
critical care unit (critical care unit mortality) and at ultimate dis-
charge from an acute hospital (ultimate hospital mortality).
Activity
Length of stay in the critical care unit was calculated (in frac-
tion of days) from the date/time of admission to and date/time
of discharge from or death in the critical care unit. For critical
care unit survivors, post-discharge length of stay in hospital
was calculated (in days) from the date of discharge from the
critical care unit and date of ultimate discharge from an acute
hospital or death in hospital. Transfers out to another ICU were
identified as critical care unit survivors whose destination fol-
lowing discharge from the unit was an ICU in the same or
another hospital. Readmissions to the critical care unit in the
same hospital stay were identified from the postcode, date of
birth, and gender and were confirmed by the participating
units.
Analyses
The case mix, outcome, and activity of admissions with SAP
were described using the variables defined above with num-
bers and percentages (for categorical variables) or medians
and interquartile ranges (for continuous variables).
Ultimate hospital mortality was also reported by the number of
modified Glasgow criteria and the APACHE II score. The abil-
ity of the modified Glasgow criteria to discriminate survivors
from non-survivors was explored with receiver operatingPage 2 of 8
(page number not for citation purposes)
Available online http://ccforum.com/content/11/S1/S1characteristic (ROC) curves. The ROC curve for the number
of modified Glasgow criteria was compared to those for the
APACHE II score and for the 12 individual physiological
parameters listed above.
The effect of case mix on length of stay in the critical care unit
was explored by comparing median lengths of stay by quartiles
of APACHE II score and survival status. All analyses were per-




In total, 2,677 admissions were identified as SAP, represent-
ing 1.2% of all admissions in the CMPD. Of these, 2,376
(88.8%) were coded as acute pancreatitis, 159 (5.9%) as
infective pancreatitis, and 142 (5.3%) as chronic pancreatitis.
All were considered to represent SAP because their pancrea-
titis was recorded as the primary reason for admission to the
critical care unit. Admissions coded with chronic pancreatitis
were assumed to have a severe acute exacerbation of chronic
pancreatitis.
Case mix
The case mix of admissions with SAP is summarised in Table
1. The age and gender distributions were comparable to those
of all admissions in the CMPD [9]; however, as one would
expect, the majority of admissions (84%) were non-surgical.
Serious conditions in the past medical history were rare, and
only 8, 13, and 27 admissions met the definitions of hepatic
encephalopathy, biopsy-proven cirrhosis, and steroid treat-
ment, respectively. The median APACHE II APS (for eligible
admissions) was 13, and the median APACHE II score was
17. Between 14% and 72% of admissions met each of the
seven modified Glasgow criteria.
Outcome
Of all admissions with SAP, 31% died in the admitting critical
care unit (Table 2). Of all patients with SAP admitted to a crit-
ical care unit (excluding readmissions of the same patient
within the same hospital stay), 42% died before ultimate dis-
charge from an acute hospital (Table 2). Increasing numbers
of modified Glasgow criteria were associated with increasing
mortality, rising from 13% for admissions meeting no modified
Glasgow criteria to 100% for the five admissions meeting all
seven modified Glasgow criteria (Figure 1). Ultimate hospital
mortality also increased with increasing APACHE II score, ris-
ing from 6% for admissions with an APACHE II score below
10 to 100% for the 13 admissions with an APACHE II score
of 40 or higher (Figure 2).
Areas under the ROC curves (aROCs) for the number of mod-
ified Glasgow criteria, APACHE II score, and 12 physiological
parameters are shown in Table 3. The number of modified
Glasgow criteria showed moderate ability to discriminate
between hospital survivors and non-survivors (aROC =
0.669), but this was exceeded by the APACHE II score
(aROC = 0.804) and four of the individual physiological
parameters: highest serum urea, lowest arterial pH, highest
serum creatinine, and lowest serum albumin. The ROC curves
for the number of modified Glasgow criteria, the APACHE II
score, and these four physiological parameters are shown in
Figure 3.
Activity
Overall median length of stay in the critical care unit was simi-
lar for survivors and non-survivors (3.7 versus 3.8 days) (Table
2). However, median length of stay increased with increasing
severity of illness for survivors and decreased with increasing
severity of illness for non-survivors (Figure 4). Length of stay in
hospital after discharge from the critical care unit was also
similar for hospital survivors and non-survivors (median 15 ver-
sus 14 days) (Table 2), although the lengths of stay of non-sur-
vivors were more variable (interquartile range 5 to 38 days
compared to 9 to 30 days for survivors). Five percent of all
admissions with SAP were transferred out to another ICU, and
5% of admissions represented a readmission of a patient pre-
viously admitted during the same hospital stay (Table 2).
Discussion
This paper presents case mix, outcome, and activity data for a
large cohort of patients with SAP who were identified from a
high-quality clinical database. The modified Glasgow criteria
were found to provide a simple score that summarised the
severity of acute pancreatitis, with an increasing number of
modified Glasgow criteria associated with increasing mortality
and providing moderate discrimination between hospital survi-
vors and non-survivors. However, better discrimination was
provided by the APACHE II score and by several individual
physiological measurements.
The main strength of this study is the large cohort, which is
representative of all patients with SAP who were admitted to
adult, general critical care units in the UK. Previous studies of
a comparable size have been based on hospital episode sta-
tistics [12-15], which do not allow the analysis of detailed
physiological measurements which was possible in this study.
Previous studies with detailed clinical data have been much
smaller and have tended to concentrate on admissions from
single or small numbers of specialist centres. Even the studies
used to develop scoring systems have been based on
between 100 [6] and 405 [8] patients with pancreatitis.
The main weakness of this study is the reliance on data col-
lected for a different purpose. Of the severity scoring systems
for acute pancreatitis, we opted to use the modified Glasgow
criteria as these had the greatest overlap with the data
included in the CMPD. Even so, data were not available for
one of the eight criteria (lactate dehydrogenase), and it was
necessary to score the criteria during a 24-hour period ratherPage 3 of 8
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Case mix for patients with severe acute pancreatitis who were admitted to adult, general critical care units
Case mix N Median (IQR) or n (%)








Past medical historyc 2,633
Biopsy-proven cirrhosis 13 (0.5)
Hepatic encephalopathy 8 (0.3)
Steroid treatment 27 (1.0)
Mechanical ventilationc 2,671 1,242 (46.5)
Physiologya
Lowest PaO2, kPa 2,470 9.8 (8.6–11.3)
Lowest PaO2/FIO2, kPa 2,467 20.4 (13.7–29.8)
Lowest arterial pH 2,467 7.30 (7.20–7.36)
Highest serum urea, mmol/l 2,307 9.3 (5.3–16.0)
Highest serum creatinine, μmol/l 2,559 112 (78–212)
Highest serum glucose, mmol/l 2,243 8.8 (6.9–11.5)
Highest total serum bilirubin, μmol/l 1,969 20 (12–37)
Lowest total serum calcium, mmol/l 1,791 1.86 (1.62–2.08)
Lowest ionised serum calcium, mmol/l 548 1.1 (0.97–1.84)
Lowest serum albumin, g/l 2,118 22 (17–27)
Highest white blood cell count, × 109/l 2,556 14.2 (10.3–19.4)
Lowest platelet count, × 109/l 2,320 174 (122–240)
APACHE IIa 2,434b
Acute Physiology Score 13 (9–17)
APACHE II score 17 (13–22)
Modified Glasgow criteriac 2,677
Serum albumin <32 g/l 1,926 (71.9)
Age >55 years 1,729 (64.6)
Total serum calcium <2 mmol/l 1,179 (44.0)
White blood cell count >15 × 109/l 1,163 (43.4)
Serum glucose >10 mmol/l 826 (30.9)
Serum urea >16 mmol/l 573 (21.4)
PaO2 <8 kPa 375 (14.0)
aValues expressed as median (IQR). bExclusion criteria: age less than 16 years, length of stay less than 8 hours. cValues expressed as number (percentage). APACHE, 
Acute Physiology and Chronic Health Evaluation; FIO2, fractional inspired oxygen; IQR, interquartile range; N, number of non-missing observations; PaO2, arterial 
oxygen tension.Page 4 of 8
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modified Glasgow criteria for predicting outcome as some
studies have noted that severity of pancreatitis may worsen
after the first 24 hours [16,17]. Furthermore, the modified
Glasgow criteria were not designed for predicting outcomes
in patients with SAP, but rather to identify SAP.
Consensus criteria exist for the definition of SAP [18], but it
was not possible to match these criteria in the CMPD. We feel
that a diagnosis of pancreatitis as the primary reason for
admission to a critical care unit can be considered to be a rea-
sonable pragmatic definition of SAP. The lead author of the
consensus criteria has also noted that in the more than 10
years since their conception, they remain poorly validated [19].
A consensus conference on the management of critically ill
patients with SAP in 2004 [20] led to the first international rec-
ommendations regarding the question of when patients
Table 2
Unit and hospital outcome and activity for admissions with severe acute pancreatitis
Outcome N Deaths Percentage
Critical care unit mortality 2,677 818 30.6
Ultimate hospital mortalitya 2,473 1,035 41.9
Activity N Median IQR
Length of stay in days
Critical care unit Survivors 1,854 3.7 1.6–10.1
Non-survivors 814 3.8 1.1–13.4
All 2,668 3.8 1.4–11.0
Post-dischargea,b Hospital survivors 1,427 15 9–30
Non-survivors 220 14 5–38
All 1,647 15 8–30
Activity N n Percentage
Transferred out to another 
intensive care unit
2,677 135 5.0
Readmission within the 
same hospital stay
2,677 131 4.9
aExcluding readmissions within the same hospital stay. bCritical care unit survivors only. IQR, interquartile range; N, number of non-missing 
observations.
Figure 1
Ultimate hospital mortality by total number of modified Glasgow criteriali  t tal nu ber of modified Glasgow criteria. 
CI, confidence interval.
Figure 2
Ultimate hospital mortality by Acute Physiology and Chronic Health Evalu tion (APACHE) II score
Evaluation (APACHE) II score. CI, confidence interval.Page 5 of 8
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Area under the receiver operating characteristic curve for ultimate hospital mortality
Variable Na aROC 95% CI
Number of modified Glasgow criteria 2,473 0.669 0.648–0.691
APACHE II score 2,369 0.804 0.786–0.821
Highest serum urea, mmol/l 2,140 0.771 0.751–0.791
Lowest arterial pH 2,288 0.768 0.748–0.788
Highest serum creatinine, μmol/l 2,370 0.763 0.744–0.783
Lowest serum albumin, g/l 1,972 0.682 0.658–0.706
Lowest PaO2/FIO2, kPa 2,291 0.660 0.638–0.683
Lowest total serum calcium, mmol/l 1,663 0.617 0.589–0.645
Lowest platelet count, × 109/l 2,152 0.599 0.574–0.623
Lowest PaO2, kPa 2,291 0.565 0.542–0.589
Highest serum glucose, mmol/l 2,078 0.560 0.534–0.585
Highest total serum bilirubin, μmol/l 1,826 0.545 0.518–0.572
Lowest ionised serum calcium, mmol/l 515 0.527 0.476–0.578
Highest white blood cell count, × 109/l 2,368 0.524 0.500–0.549
aExcluding readmissions within the same hospital stay and admissions missing ultimate hospital outcome. APACHE, Acute Physiology and 
Chronic Health Evaluation; aROC, area under the receiver operating characteristic curve; CI, confidence interval; FIO2, fractional inspired oxygen; 
N, number of non-missing observations; PaO2, arterial oxygen tension.Page 6 of 8
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group concluded that the use of disease-specific and global
severity scores may assist in the identification of high-risk
patients but should not replace close clinical observation. The
levels of discrimination observed in this study support this
recommendation.
Conclusion
SAP requiring admission to a critical care unit is associated
with high mortality and long length of stay; this review identi-
fied 2,677 admissions to 159 critical care units with hospital
mortality of 42% and a median length of stay in critical care of
four days. Although the modified Glasgow criteria provide a
simple tool for summarising the severity of acute pancreatitis,
they were not designed for predicting hospital mortality in
patients with SAP requiring critical care. Good discrimination
between survivors and non-survivors was obtained by using
the APACHE II score. Good discrimination was also found for
four individual physiological parameters–highest serum urea,
lowest arterial pH, highest serum creatinine, and lowest serum
albumin–suggesting that it may be possible to produce a new
score to provide a more accurate outcome prediction for this
population.
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Key messages
• SAP requiring admission to a critical care unit is associ-
ated with high mortality and long length of stay.
• Increasing numbers of modified Glasgow criteria were 
associated with increasing hospital mortality, although 
the criteria were not designed for this purpose and only 
seven of the eight criteria could be identified in these 
data.
• Good discrimination was obtained with the APACHE II 
score and with four individual physiological parameters: 
highest serum urea, lowest arterial pH, highest serum 
creatinine, and lowest serum albumin.Page 8 of 8
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